Navigation Links
Sensortech Announces New, Ligament Balancing TKA Smart Insert

PENDLETON, S.C., Feb. 6, 2013 /PRNewswire/ -- Sensortech Corporation announced advancement of their new, orthopedic knee alignment product, the Force Check Knee Replacement Smart Insert designed for improving total knee arthroplasty (TKA) surgeries.

Incorporating FDA-approved Bluetooth 4 low energy technology, and FDA-approved plastics technology, the Force Check Knee Replacement Smart Insert can readily adapt to all TKA replacement components on the market. The insert will increase TKA profitability through reduced operating and patient recovery times, faster healing times, reduced component wear, superior pain management and fewer revisions.

With FDA approval, Sensortech's technology could also become a "leave in" device, measuring TKA component performance throughout the replacement's operational life. 

 "The new Smart Insert is a patented, superior solution. It provides real time condyle contact pressure (force) as well as contact location and contact patch movement tracking throughout the flexion test—something unique to the market today. We know the demand for this device is there.  Surgeons and medical device manufacturers have been telling us they need our insert," said inventor Dr. Andrew Clark .

To exploit the market value of this device and assist in acquiring a 510K to develop the "leave in" solution, Sensortech is seeking acquisition partner(s).  The company has also positioned their Force Check Knee Replacement Smart Insert device as an initial entry into a line of medical device smart inserts for all types of joint replacement surgeries.  For more information about Sensortech go to or contact Sensor Tech Corporation at, (864) 298-0684.

This press release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties. Actual results for fiscal year 2013 and beyond could differ materially from Sensortech Corporation's current expectations. Factors that could cause Sensortech Corporation's results to differ materially from those expressed in forward-looking statements include: variation in demand and acceptance of products and services, general business and economic conditions beyond Sensortech Corporation's control, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and Sensortech Corporation's success in attracting and retaining key personnel. Sensortech Corporation undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.

SOURCE Sensortech Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Emerald Logic announces collaboration with Kings College London on quantitative biomarker discovery
2. Uroplasty Announces Executive Changes In US Sales Organization
3. Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information
4. Blue Belt Technologies Announces Hiring of U.S. Commercial Leadership Team
5. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
6. MGC Diagnostics Corporation Announces National Jewish Health Selects the Company as Preferred Provider for Cardiopulmonary Diagnostic Instrumentation
7. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
8. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Requirements
9. BD Announces Results for 2013 First Fiscal Quarter
10. Hologic Announces First Quarter Fiscal 2013 Operating Results
11. Cyberonics Announces Update On Hagerty Lawsuit
Post Your Comments:
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... ) has announced the addition of ... Testing Market: Campylobacter, Cryptosporidium, E. Coli, ... Yersinia" report to their offering. ... announced the addition of the ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... --  Craneware, Inc ., the healthcare market leader ... company will showcase a new version of its ... at the American Society for Health-System Pharmacists (ASHP) ... features are focused on simplifying and streamlining the ... pharmacy charges to ensure compliance and optimal revenue ...
Breaking Medicine Technology:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- ... of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays ... film for accurate interpretation by the radiologist. The marking utensils are so small, ... Calif., has found a way to alleviate this problem. , He developed the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... Burlington, MA (PRWEB) , ... December 01, 2015 , ... ... the release of Clarity, the latest addition to the devices for sale in the ... technologies, 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - CES, Las Vegas, ... Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, where they will ... Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among ...
Breaking Medicine News(10 mins):